Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

However, a recent study from Sunnybrook Research Institute offers some hope. Researchers found that a type of diabetes ...

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...